3-BUTYL-1-CHLORO-5,10-DIHYDRO-8-(2-(2H-TETRAZOL-5-YL)PHENYL)IMIDAZO(1,5-B)ISOQUINOLINE
UNII W776YNY7DJ
Substance Identification & Data
This profile provides standardized clinical and technical data for 3-butyl-1-chloro-5,10-dihydro-8-(2-(2h-tetrazol-5-yl)phenyl)imidazo(1,5-b)isoquinoline, uniquely identified by the FDA Unique Ingredient Identifier (UNII) W776YNY7DJ.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 165276-38-0 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C22H21ClN6 RSKIKNQMNCWQMT-UHFFFAOYSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 3-butyl-1-chloro-5,10-dihydro-8-(2-(2h-tetrazol-5-yl)phenyl)imidazo(1,5-b)isoquinoline. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.